Trial Profile
Pharmacokinetic Evaluation of Different Rifabutin Dosing Strategies in African TB Patients on Lopinavir/ritonavir-based ART
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Mar 2011
Price :
$35
*
At a glance
- Drugs Rifabutin (Primary) ; Antiretrovirals; Lopinavir/ritonavir
- Indications HIV infections; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 18 Mar 2011 New trial record
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.